FDA Import Refusal SCS-4314134-5/10002/1 — Sun Pharmaceutical Industries Ltd
The FDA refused shipment SCS-4314134-5/10002/1 from Sun Pharmaceutical Industries Ltd (India) on Nov 3, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 3, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75